killer cure

Lindalee Tracey, Canada / France, 2005
Synopsis

The antibiotic miracle is ending. World-wide resistance grows. Hospital infections increase. Superbugs attack. In the former Soviet republic of Georgia, scientists fight back with bacteriophage. And a desperate American patient travels to Tbilisi in hopes that a killer virus will cure him. Following the personal journey of this desperate man in search of a medical miracle in the former Soviet Union - where a long-forgotten Canadian discovery continues to heal those with little chance to live - this documentary reveals the catastrophic consequences of reckless misuse of antibiotics and investigates the strange story of the bacteriophage.

Docs for Sale information

Available versions: Unknown, video,
Spoken languages: Georgian, English
Subtitling: English
Sales remarks: -
IDFA is revamping its competitions September 1, 2015 | From the next festival edition, the IDFA juries will grant two awards in each competition: one for best documentary, and a special jury award. A new award will also be presented for the best international youth documentary. All jury awards will be presented on Wednesday, November 25.
Help crowdfund Laila at the Bridge September 1, 2015 | Against all odds, an Afghan woman risks everything to save heroin addicts in Kabul, and ends up also saving herself in Laila at the Bridge. The film was previously supported by the IDFA Bertha Fund. Now, directors Gulistan Mirzaei and Elissa Sylvia Mirzaei need your help to finish their film!
IDFA Awards given out in Durban, Montevideo and Sarajevo August 27, 2015 | Three IDFA Awards were handed out over the summer to promising projects pitched at three international film markets. As part of the awards, all winners will attend IDFA in November.

Twitter

IDFAindustry @IDFAindustry 9 hour ago
More awards and new competition for international youth documentary at #IDFA15 -- press release: https://t.co/eTLkBFTUZ8
Open
IDFAindustry @IDFAindustry 1 day ago
@daniellebeverly We hope so too! The entry deadline is tomorrow...
Open
VPRO Oxfam Novib de Volkskrant BankGiro Loterij Fonds 21 Fonds 21